KOBUNAI Takashi | Taiho Pharmaceutical Co., Ltd.,Hanno Research Center
スポンサーリンク
概要
関連著者
-
Yamazaki Y
Cancer Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Yamada Y
Taiho Pharmaceutical Co. Ltd. Saitama
-
KOBUNAI Takashi
Taiho Pharmaceutical Co., Ltd.,Hanno Research Center
-
UTSUGI Teruhiro
Taiho Pharmaceutical Co., Ltd.,Hanno Research Center
-
Aoyagi Yoshimi
Taiho Pharmaceutical Co. Ltd. Hanno Research Center
-
Utsugi T
Taiho Pharmaceutical Co. Ltd. Hanno Research Center
-
Kobunai Takashi
Taiho Pharmaceutical Co. Ltd. Hanno Research Center
-
Wierzba Konstanty
東京都医学研究機構東京都臨床医学総合研究所
-
Wierzba Konstanty
東京大学 薬
-
Wierzba Konstanty
Taiho Pharmaceutical Company Hanno Research Center
-
Wierzba Konstanty
Faculty Of Pharmaceutical Sciences University Of Tokyo
-
Wierzba Konstanty
Taiho Pharmaceutical Co. Ltd. Hanno Research Center
-
YAMADA Yuji
Taiho Pharmaceutical Co. Ltd
-
AOYAGI Yoshimi
Hanno Research Center, Taiho Pharmaceutical Co., Ltd.
-
YAMADA Yuji
Hanno Research Center, Taiho Pharmaceutical Co., Ltd.
-
AOYAGI Yoshimi
Taiho Pharmaceutical Co., Ltd.,Hanno Research Center
-
KOBUNAI Takashi
Hanno Research Center, Taiho Pharmaceutical Co., Ltd
-
UTSUGI Teruhiro
Hanno Research Center, Taiho Pharmaceutical Co., Ltd
-
OH-HARA Tomoko
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Oh-hara Tomoko
Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Utsugi Teruhiro
Hanno Research Center Taiho Pharmaceutical Co. Ltd
-
Yamada Yuji
Hanno Research Center Taiho Pharmaceutical Co.
著作論文
- Establishment and Characterization of 6-[[2-(Dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride (TAS-103)-resistant Cell Lines
- In vitro Antitumor Activity of TAS-103, a Novel Quinoline Derivative That Targets Topoisomerases I and II